BSE · BRAWN

Brawn Biotech Limited

Sector: Healthcare · ISIN: INE899B01015

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#4,643

of 5,004 stocks

🏆 New peak

▲ 611W

Peak #4,643 · 01 Oct 2026

Brawn Biotech Limited, a microcap Healthcare business, trades at an undemanding earnings multiple, is growing revenue rapidly, and generates a high return on equity. Ownership as of Jun 2026.

Market Cap

7.07 Cr

P/E Ratio

7.23

P/B Ratio

1.63

ROE

21.67%

ROCE

0.10%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	6.08 Cr	1.98 Cr	4.31 Cr	4.89 Cr
Net Profit	15.43 L	58.33 L	4.98 L	7.14 L
EPS	0.52	1.95	0.17	0.25
Operating Profit	15.45 L	-35.39 L	4.99 L	-1.78 L

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

52.94%

Public

47.06%

PUBLIC BREAKDOWN

FII

0.00%

DII

0.35%

MF (within DII)

0.35%

Individuals

31.74%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-Date	Type	Details
12 Sep 2018	Dividend	Final Dividend - Rs. - 1.0000
14 Sep 2017	Dividend	Final Dividend - Rs. - 1.5000

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs